Literature DB >> 29357676

Difference of seasonal variation between glycated albumin and glycated haemoglobin.

Karin Tanaka1, Shu Meguro1, Masami Tanaka1, Junichiro Irie1, Yoshifumi Saisho1, Hiroshi Itoh1.   

Abstract

Background Glycated albumin reflects 2-3-week glycaemic controls, and in addition to glycated haemoglobin, it has been used as a glycaemic control indicator. We presumed that glycated albumin also has seasonal variations and is related to temperature, similar to glycated haemoglobin. Methods The subjects were diabetic outpatients from April 2007 to March 2013. This resulted in the enrolment of 2246 subjects and the collection of a total of 53,968 measurements. Mean glycated haemoglobin, glycated albumin, and plasma glucose were calculated for each month over six years. The associations of the measures with each other and the average temperature for each month in Tokyo were assessed using Spearman rank correlation coefficients. Results Plasma glucose was highest in January and lowest in May. Glycated haemoglobin was highest in March and lowest in September. Glycated albumin was highest in May and lowest in December. Glycated albumin tended to have a disjunction with plasma glucose in winter. Glycated haemoglobin had seasonal variation, but glycated albumin did not. Plasma glucose and glycated haemoglobin showed significant negative correlations with temperature (rs = -0.359, P < 0.001, rs = -0.449, P < 0.001, respectively), but glycated albumin did not. However, glycated albumin was inter-correlated with plasma glucose (rs = 0.396, P < 0.001) and glycated haemoglobin (rs = 0.685, P < 0.001), and glycated haemoglobin was inter-correlated with plasma glucose (rs = 0.465, P < 0.001). Conclusion Glycated albumin and glycated haemoglobin showed different seasonal variations from each other over the six-year study period. Thus, further studies to identify factors that contribute to glycated albumin are needed.

Entities:  

Keywords:  Glycated albumin; HbA1c; glycaemic control; seasonal variation

Mesh:

Substances:

Year:  2018        PMID: 29357676     DOI: 10.1177/0004563218755816

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  3 in total

1.  Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis.

Authors:  Kazutoshi Sugiyama; Shu Meguro; Yoshifumi Saisho; Junichiro Irie; Masami Tanaka; Hiroshi Itoh
Journal:  Heliyon       Date:  2019-02-21

2.  The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes.

Authors:  Edyta Sutkowska; Dominik M Marciniak; Karolina Sutkowska; Karolina Biernat; Justyna Mazurek; Natalia Kuciel
Journal:  Endocrine       Date:  2022-01-24       Impact factor: 3.925

3.  Seasonal variations and the influence of COVID-19 pandemic on hemoglobin A1c, glycoalbumin, and low-density lipoprotein cholesterol.

Authors:  Kohzo Takebayashi; Mototaka Yamauchi; Kenji Hara; Takafumi Tsuchiya; Koshi Hashimoto
Journal:  Diabetol Int       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.